Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: IMPAX PHARMACEUTICALS, INC.

Complaint inspection · Health discipline

On , OSHA opened a complaint health inspection of IMPAX PHARMACEUTICALS, INC. in 42329 OSGOOD RD, UNIT E, FREMONT, CA 94539 (NAICS 325412). OSHA activity number 125646885.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Impax Pharmaceuticals, INC. — free Get an email when a new federal OSHA severe-injury report for Impax Pharmaceuticals, INC. is published. One employer, no account, unsubscribe in one click.
Site address
42329 OSGOOD RD, UNIT E
City
FREMONT
State
CA
ZIP
94539
Inspection type
Complaint (B)
Scope
Complete (A)
Discipline
Health
Advance notice
No
Union status
N
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
325412
SIC code (legacy)
2834
Employees
26
Ownership type
A

3 citations on file for this inspection.

5144 F01

Other-than-serious 1 instance 1 exposed
Issued
Nov 3, 1997
Abate by
Dec 3, 1997
Penalty
Initial $275 · Current $275

5144 H

Other-than-serious 1 instance 1 exposed
Issued
Nov 3, 1997
Abate by
Dec 3, 1997
Penalty
Initial $25 · Current $25

5191 F04 B

Other-than-serious 1 instance 1 exposed
Issued
Nov 3, 1997
Abate by
Dec 3, 1997
Penalty
Initial $275 · Current $275

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 125646885.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.